Alamar Biosciences, Inc.
ALMR- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0002104204
No open-market purchases or sales by Alamar Biosciences, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $664.3M in total; 3 superinvestors hold it, including ARK Invest and HHLR Advisors (Hillhouse).
Superinvestors holding ALMR, Q2 2026
3 superinvestors report holding Alamar Biosciences, Inc. on Form 13F, worth $64.8M in total. Weight is Alamar Biosciences, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 0.2% | 1,373,959 | $37.2M | New |
| HHLR Advisors (Hillhouse)Zhang Lei | 3.1% | 956,462 | $25.9M | New |
| Soros Fund ManagementGeorge Soros | <0.1% | 60,000 | $1.63M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ALMR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
3 superinvestors holding at quarter end